Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This is prospective randomized control trial study. The aim of this study is to evaluate the
efficacy of Iodopovidone solution for pleurodesis in palliative malignant pleural effusion
(MPE) patients comparing to Talc. All adult patients who diagnosed MPE by cytology regardless
primary tumor between December 1, 2015 and November 29, 2016 at Maharaj Nakorn Chiang Mai
Hospital, Chiang Mai University, Chiang Mai, Thailand will be enrolled in this study. The
inform and consent will be applied in all patients before treatment. Patients will be
randomized to two groups; Iodopovidone group (intervention group) and Talc group (control
group)